Call for Papers  

Article Details

Research Article

Identification of Drug Targets and Agents Associated with Ferroptosis-related Osteoporosis Through Integrated Network Pharmacology and Molecular Docking Technology

[ Vol. 30 , Issue. 14 ]


Kailun Huo, Yiqian Yang, Tieyi Yang, Weiwei Zhang* and Jin Shao*   Pages 1103 - 1114 ( 12 )


Background: Osteoporosis is a systemic bone disease characterized by progressive reduction of bone mineral density and degradation of trabecular bone microstructure. Iron metabolism plays an important role in bone; its imbalance leads to abnormal lipid oxidation in cells, hence ferroptosis. In osteoporosis, however, the exact mechanism of ferroptosis has not been fully elucidated.

Objective: The main objective of this project was to identify potential drug target proteins and agents for the treatment of ferroptosis-related osteoporosis.

Methods: In the current study, we investigated the differences in gene expression of bone marrow mesenchymal stem cells between osteoporosis patients and normal individuals using bioinformatics methods to obtain ferroptosis-related genes. We could predict their protein structure based on the artificial intelligence database of AlphaFold, and their target drugs and binding sites with the network pharmacology and molecular docking technology.

Results: We identified five genes that were highly associated with osteoporosis, such as TP53, EGFR, TGFB1, SOX2 and MAPK14, which, we believe, can be taken as the potential markers and targets for the diagnosis and treatment of osteoporosis. Furthermore, we observed that these five genes were highly targeted by resveratrol to exert a therapeutic effect on ferroptosis-related osteoporosis.

Conclusion: We examined the relationship between ferroptosis and osteoporosis based on bioinformatics and network pharmacology, presenting a promising direction to the pursuit of the exact molecular mechanism of osteoporosis so that a new target can be discovered for the treatment of osteoporosis.


Osteoporosis, ferroptosis, resveratrol, bioinformatics, network pharmacology, molecular docking.


Read Full-Text article